ConductScience.org, home

Paper3965362

Pharmacology of propranolol in patients with cirrhosis and portal hypertension.

Arthur MJ and 5 others. Gut, 1985. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Pharmacology of propranolol in patients with cirrhosis and portal hypertension. Papers, record 3965362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3965362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacology of propranolol in patients with cirrhosis and portal hypertension.
PubMed
Journal
Gut
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.83
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arthur MJM J
2Tanner ARA R
3Patel CC
4Wright RR
5Renwick AGA G
6George CFC F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypertension, PortalMajor topic
Liver CirrhosisMajor topic
PropranololMajor topic
Aged
Female
Heart Rate
Humans
Male
Middle Aged
Protein Binding

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15429105Method for measuring cerebral dysfunction in patients with liver disease.Br Med J1970https://conductscience.org/library/papers/5429105PubMed
24997528Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.Br Heart J1971https://conductscience.org/library/papers/4997528PubMed
35054586The disposition of propranolol. I. Elimination during oral absorption in man.Pharmacology1972https://conductscience.org/library/papers/5054586PubMed
44723255Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723255PubMed
54198771The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4198771PubMed
64541913Transection of the oesophagus for bleeding oesophageal varices.Br J Surg1973https://conductscience.org/library/papers/4541913PubMed
71271238Contribution of the liver to overall elimination of propranolol.J Pharmacokinet Biopharm1976https://conductscience.org/library/papers/1271238PubMed
8947650Plasma binding and the affinity of propranolol for a beta receptor in man.Clin Pharmacol Ther1976https://conductscience.org/library/papers/947650PubMed
9973958A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973958PubMed
10659528High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.J Chromatogr1978https://conductscience.org/library/papers/659528PubMed
1182206Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.N Engl J Med1978https://conductscience.org/library/papers/82206PubMed
12476887Suppression of chronic ventricular arrhythmias with propranolol.Circulation1979https://conductscience.org/library/papers/476887PubMed
137356891Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7356891PubMed
146105342Propranolol--a medical treatment for portal hypertension?Lancet1980https://conductscience.org/library/papers/6105342PubMed
157029276Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.N Engl J Med1981https://conductscience.org/library/papers/7029276PubMed
167066175Intravenous propranolol in patients with inflammation.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7066175PubMed
176411235Precipitation of hepatic encephalopathy by propranolol in cirrhosis.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6411235PubMed
186361553Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.N Engl J Med1983https://conductscience.org/library/papers/6361553PubMed

Download CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
38738176Propranolol can correct prolonged QT intervals in patients with cirrhosis.Front Pharmacol2024https://conductscience.org/library/papers/38738176PubMed
37576859Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life.Saudi Pharm J2023https://conductscience.org/library/papers/37576859PubMed
33762817Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.Drug Des Devel Ther2021https://conductscience.org/library/papers/33762817PubMed
24906133A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.PLoS One2014https://conductscience.org/library/papers/24906133PubMed
22969313The Pharmacokinetics of Single Dose vs Steady-State Doses of Propranolol in Cirrhotic Malay Patients.Malays J Med Sci2002https://conductscience.org/library/papers/22969313PubMed
16898077H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage.Eur J Drug Metab Pharmacokinet2006https://conductscience.org/library/papers/16898077PubMed
3689632A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3689632PubMed
2886244Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.Clin Pharmacokinet1987https://conductscience.org/library/papers/2886244PubMed
2680433Safety of propranolol in portal hypertension. Conventional and long acting formulations.Drugs1989https://conductscience.org/library/papers/2680433PubMed
2572412Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.Drugs1989https://conductscience.org/library/papers/2572412PubMed
2569324Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2569324PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3965362

GET https://conductscience.org/api/papers/v1/3965362/authors